Vital Hepatitis Reactivation with Anti-Tumor Necrosis Factor-Alpha: What Do We Know?

被引：0
作者：
Zuckerman, Eli [1 ]
机构：
[1] Technion Israel Inst Technol, Rappaport Fac Med, Carmel Med Ctr, Liver Unit, Haifa, Israel
来源：
ISRAEL MEDICAL ASSOCIATION JOURNAL | 2013年 / 15卷 / 06期
关键词：
reactivation; hepatitis B virus (HBV); hepatitis C virus (HCV); anti-tumor necrosis factor-alpha (anti-TNF alpha); preemptive treatment; immunosuppression; B-VIRUS INFECTION; CYTOTOXIC CHEMOTHERAPY; C INFECTION; DISEASE; PREVENTION; LAMIVUDINE; THERAPY; SAFETY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：298 / 300
页数：3
相关论文
共 50 条
  • [41] Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets' Disease-Associated Uveitis: A Systematic Review and Meta-Analysis
    Hu, Yunwei
    Huang, Zhaohao
    Yang, Shizhao
    Chen, Xiaoqing
    Su, Wenru
    Liang, Dan
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [42] Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
    Scheinberg, Morton
    Castaneda-Hernandez, Gilberto
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (06)
  • [43] Neutropenia in Patients Receiving Anti-Tumor Necrosis Factor Therapy
    Hastings, Richard
    Ding, Tina
    Butt, Sayqa
    Gadsby, Kate
    Zhang, Weiya
    Moots, Robert J.
    Deighton, Chris
    ARTHRITIS CARE & RESEARCH, 2010, 62 (06) : 764 - 769
  • [44] Salivary and plasmatic levels of tumor necrosis factor-alpha do not correlate with the clinicopathological profile in breast cancer patients
    Opolski, Marcelo Marcos
    Maito, Vitor Teixeira
    Bufalo Kawassaki, Aedra Carla
    da Silva, Janaina Carla
    Kern, Rodrigo
    Rech, Daniel
    de Oliveira, Stefania Tagliari
    Micheletti, Pamela Lonardoni
    Panis, Carolina
    Grassiolli, Sabrina
    PRECISION MEDICAL SCIENCES, 2022, 11 (04): : 155 - 160
  • [45] Safety of Anti-Tumor Necrosis Factor Agents in Rheumatic Potential Carriers of Occult Hepatitis B Virus
    Giannitti, Chiara
    Sebastiani, Gian Domenico
    Manganelli, Stefania
    Galeazzi, Mauro
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (04) : 781 - 782
  • [46] The use of anti-interleukin-1 agents and tumor necrosis factor-alpha inhibitors in renal transplant recipients
    Yazisiz, Veli
    Yilmaz, Vural Taner
    Ucar, Ismail
    Dandin, Ozgur
    Aslan, Bengisu
    Erbasan, Funda
    Kocak, Huseyin
    Terzioglu, Mustafa Ender
    ARCHIVES OF RHEUMATOLOGY, 2021, 36 (03) : 366 - 374
  • [47] Periodontal Conditions and Tumor Necrosis Factor-Alpha Level in Gingival Crevicular Fluid of Scleroderma Patients
    Elimelech, Rina
    Mayer, Yaniv
    Braun-Moscovici, Yolanda
    Machtei, Eli E.
    Balbir-Gurman, Alexandra
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (09): : 549 - 553
  • [48] Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor a Therapy for Inflammatory Bowel Disease
    Lee, Ji Min
    Wei, Shu-Chen
    Lee, Kang-Moon
    Ye, Byong Duk
    Mao, Ren
    Kim, Hyun-Soo
    Park, Soo Jung
    Park, Sang Hyoung
    Oh, Eun Hye
    Im, Jong Pil
    Jang, Byung Ik
    Kim, Dae Bum
    Takeuchi, Ken
    GUT AND LIVER, 2022, 16 (03) : 396 - 403
  • [49] Treatment of Subcorneal Pustular Dermatosis (Sneddon-Wilkinson Disease) With Anti-Tumor Necrosis Factor Alpha
    Guerin, Clemence, Jr.
    Beylot-Barry, Marie
    Frouin, Eric
    Hainaut, Ewa
    Regnault, Marie Masson
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [50] Tumor Necrosis Factor-Alpha Polymorphism and Susceptibility to Multiple Sclerosis in the Iranian Population
    Rahmanian, Masoomeh
    Kargar, Mohammad
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2015, 17 (01) : 1 - 4
12345